Abstract Introduction: Lung cancer was the most commonly diagnosed cancer as well as the leading cause of cancer death in males in 2008 globally.
Introduction
At the end of the 20th century, Bronchogenic Carcinoma had become one of the leading causes of preventable death. It was a rare disease at the start of that century, but exposures to new etiologic agents and an increasing life span combined to make lung cancer a scourge of the 20th century. Lung cancer is the most common malignancy worldwide and is the leading cause of cancer deaths in men and women [1] .
Lung cancer was the most commonly diagnosed cancer as well as the leading cause of cancer death in males in 2008 globally. Among females, it was the fourth most common diagnosed cancer and the second leading cause of cancer death. Lung cancer accounted for 13% (1.6 million) of the total cases and 18% (1.4 million) of the death in 2008 [2] .
Patients and methods
This retrospective study was carried out in the Department of Chest Medicine of Cairo University Hospital, in which four hundred and four (404 cases) histopathologically and/or cytologically confirmed cases of bronchogenic carcinoma were included in the study. These patients were admitted during the last 10 years (from 2001 to 2010).
Data regarding demographics (age of the patients, sex), smoking status, histopathological type, clinical presentation, radiographic findings, the method of diagnosis and clinical stage of the disease were obtained from the files of confirmed cases of bronchogenic carcinoma.
Radiological assessment was done in all cases. The diagnosis of bronchogenic carcinoma was based on positive histopathological or cytological examination. Patients without histopathological confirmation were excluded from this study. For confirmation of diagnosis of bronchogenic carcinoma, majority of patients were subjected to fibro-optic bronchoscopy and/or CT-guided biopsy. Other diagnostic methods were open biopsy, thoracoscopy, pleural fluid and supraclavicular lymph node biopsy.
All case data were tabulated. Statistical analysis was performed using descriptive statistics of the collected data.
Results
The results are shown in Tables 1-10 and Figs. 1-9.
Discussion
Accurate epidemiological data on lung cancer in Egypt are not available since a comprehensive national population-based cancer registry is lacking. However, official statistics as well as institution and hospital-based studies show that it is the second most common cancer in men and second leading cause of cancer death, after bladder cancer [3] .
As regards to the sex distribution of bronchogenic carcinoma cases, Table 1 shows that 82.2% of cases were males and 17.8% of cases were females with a male to female ratio of 4.6:1 which is near to that reported by Elattar from the National Cancer Institute (NCI) in Egypt [3] . According to Bahader and Jazieh study the male:female ratio was 3:1 [4] .
In many of the more developed countries, the incidence of lung cancer in men has reached a plateau and is now decreasing, whereas the number of new cases in women continues to increase [5, 6] .
According to Devesa et al., male:female rate ratios varied from less than 2 in Iceland, US whites, Canada, Denmark and Sweden to more than 6 in Slovenia, Italy, and France and more than 10 in Spain [7] .
Generally, lung cancer trends among females lag behind males lung cancer rates in females are increasing in many countries [2] . In recent years, adenocarcinoma has increased as a proportion of all lung cancers diagnosed [8] . Women are more frequently diagnosed with adenocarcinoma, and this may explain the narrowing of the gap between men and women in the incidence of bronchogenic carcinoma in our study. Studying the age distribution in this work shows that, the highest incidence of bronchogenic carcinoma was in the sixth and seventh decades of life with 63.6% of the cases found in these two decades of life (Fig. 1) .
The incidence declined before the age of 40 with 5.9% of cases and after the age of 70 with 7.7% of cases, and no cases were found before age of 26 years, indicating that bronchogenic carcinoma was less common in these age groups.
Similarly, a study carried out by Karlikaya and Cakir Edis [9] and another study by Suliman et al. [10] also proved that maximum patients were in their sixth and seventh decade at the time of diagnosis of bronchogenic carcinoma.
The average age at the time of diagnosis that was reported by the Radzikowska study was 61.94 years [11] . In our study, age ranged from 26 to 90 years with 58.59 years being the average age (Table 2 ). This may be explained by that patients started smoking early in their life. The mean age in males was 58.50 years and it was 53.42 years in females.
The relation between age groups and histological cell type (Table 3) shows that the squamous cell carcinoma was common after the age of 50 years (84.1%) while the small cell carcinoma was common in the age period between 40 and 60 years (70%) and also adenocarcinoma cell type was common in the age period between 40 and 60 years (63.9%).
As regards to smoking status, there have been many studies in many parts of the world which showed a relationship between smoking and bronchogenic carcinoma. In our study, smoking habit of the patient (Fig. 2) , revealed that, the number of smokers (75.7%) is 3 folds that of non-smokers (24.3%). Study of Rawat et al., reported that smoking was the main risk factor in 81.77% patients [12] . In our study of 72 females with bronchogenic carcinoma, a high percentage of them were non-smokers (97.25% nonsmokers versus 2.8% smokers). And this explains the relatively high percentage (42.3%) of non-smokers in our study.
In male cases, the percentage of smokers was 91.6% while the percentage of non-smokers was 8.4% of male (Fig. 3) .
In our study, the percentage of non-smoking females was 97.2% versus only 2.8% of smoking females, so other risk factors other than smoking, should be considered that include exposure to environmental tobacco smoke (ETS), fumes and smoke from certain cooking fuels and environmental pollution.
In our study smoking is associated with all types of bronchogenic carcinoma. The connection between smoking and bronchogenic carcinoma was most evident among patients with squamous cell carcinoma, small cell carcinoma and large cell carcinoma and less evident among patients with adenocarcinoma (Fig. 4) .
The strength of the association between cigarette smoking and bronchogenic carcinoma varies by cell type, with the largest for squamous and small cell carcinomas and somewhat smaller for adenocarcinoma. This result is similar to that reported in another study [13] .
The different clinical presentations of the patients (Fig. 5 ) revealed that cough was the most frequent symptom in the whole group, as 347 patients (85.9%) had this complaint. According to Rawat et al. study cough was the common symptom (72.90%) [12] .
Cough is present in >65% of patients at the time lung cancer is diagnosed [14] .
In this study cough was the most common symptom (347 patients; 85.9%) and was followed by dyspnea (276 patients; 68.3%), expectoration (270 patients; 66.8%), chest pain (241 patients; 59.7%), hemoptysis (142 patients; 35.1%) weight loss (115 patients; 28.5%), and hoarseness of voice (85 patients; 21%) was also a frequent symptom. Other symptoms, as fever (16.3%), dysphagia (9.2%) and supraclavicular lymph node (1%) were not so frequent clinical presentations. In our study the incidence of symptoms was high compared to those described in the literature (Fig. 5 ) and this explained by that our patients presented late in their disease.
The radiological findings (Fig. 6 ), showed that, lung mass was the commonest radiological picture, as it occurred in 201 cases (49.8%) near to that percentage (46.31%) that was reported by Rawat et al. study [12] followed by hilar shadow (15.8%), apical opacity (13.1%),and pleural effusion (12.1%).
Cavitary lesion was found in 7.4% of cases. A prospective study by Shetty et al., found that cavitary lesion incidence was 8.6% of lung cancer [15] . Pulmonary nodule in our study occurred in 1.7% of cases, this may be explained by that most cases were presented in late stages.
Distribution of histopathologic cell types according to the radiological findings ( Table 5 ), showed that 44.4% of cases of squamous cell carcinoma presented with mass lesion followed by 25.2% of cases presented with hilar shadow and 16.6% presented radiologically with apical opacity while pleural effusion and cavitary lesion presented in 7.3% and 6% of the squamous cell carcinoma cases, respectively.
In our study, 53.8% of cases of adenocarcinoma presented with mass lesion followed by 21% of cases of adenocarcinoma presented with pleural effusion while hilar shadow incidence was 9.2% of adenocarcinoma cases. Most of cases of small cell carcinoma presented radiologically with mass lesion 66.7% followed by hilar shadow in 18.3% of small cell carcinoma cases. 51.7% of large cell carcinoma presented with mass lesion and 20.7% of large cell carcinoma with pleural effusion.
In all cell types of bronchogenic carcinoma, the mass lesion was the major radiological picture, in this study (Fig. 8) . Table 6 shows that pleural effusion was more frequent with adenocarcinoma, as 51% of cases that presented with pleural effusion were adenocarcinoma and this may be due to that most of adenocarcinoma located peripherally and it can cause pleural invasion. Table 7 shows that hilar shadows were common with squamous cell carcinoma, as 59.4% of cases presented with hilar shadows were squamous cell carcinoma followed by small cell carcinoma and adenocarcinoma (17.2%).
Apical opacity incidence was more frequent with squamous cell carcinoma, 47.2% of cases that presented with apical opacity were squamous cell carcinoma, followed by 24.4% undifferentiated carcinoma. Table 8 and Fig. 7 illustrate different methods of diagnosis that had been performed in this study, in our study, diagnosis of bronchogenic carcinoma was made by fibreoptic bronchoscopy in 275 patients (68.1%), and this percentage is near to that reported in another study which was 61.7% [16] . An important role in improving the diagnostic relevance of the fibreoptic bronchoscopy was assumed by the more frequent adoption of biopsies and trans-bronchial needle aspiration on parenchyma and mediastinal lymph nodes. The cases of bronchogenic carcinoma that was diagnosed by CT guided biopsy were 86 cases (21.3% of all cases). Table 9 shows that most cases that were diagnosed by FNAB (FNAB done under CT) was adenocarcinoma (38 patients; 44.2%), followed by squamous cell carcinoma (36 patients; 41.9%), while only 5 cases (5.8%) of the small cell carcinoma, 3 cases (3.5%) of the large cell carcinoma and 4 cases (4.7%) of the undifferentiated carcinoma were diagnosed by CT guided biopsy.
Supraclavicular lymph node biopsy was performed in 2 cases (0.5% of all cases), 1 of these cases proved to be squamous cell carcinoma, while other case was undifferentiated carcinoma. Pleural fluid cytology was positive in 9 cases (2.2% of all cases), 3 cases were adenocarcinoma, 4 cases were large cell carcinoma and 2 cases were squamous cell carcinoma. Thoracoscopy was the diagnostic procedure in 15 cases (3.7% of all cases), 60% of them were adenocarcinoma, 13.3% were squamous cell carcinoma and 20% were undifferentiated carcinoma.
Open biopsy was performed in l7cases (4.2% of all cases), as regards the histologic cell type, that most cases were adenocarcinoma (52.9%) followed by squamous cell carcinoma (23.5%).
In our study the most common histopathological cell type was squamous cell carcinoma (37.4%), followed by adenocarcinoma (29.5%), small cell carcinoma (14.9%), large cell carcinoma (7.2%) and undifferentiated carcinoma (11.1%) (Fig. 8) .
In the cell type distribution reported by Radzikowska, squamous cell carcinoma had the highest cell type incidence (52.1%) followed by small cell carcinoma (20.8%) while adenocarcinoma represented only 11.3% of the cases [11] .
According to Shetty et al., study, squamous cell carcinoma also presented 44.5% of cases followed by adenocarcinoma (18.5%) and small cell carcinoma (17.2%) [15] .
In another study by Rawat et al., they reported that 44.8% of cases were squamous cell carcinoma followed by adenocarcinoma (19.7%) and small cell carcinoma (16.75%) [12] .
In our study the incidence of squamous cell carcinoma (37.4%) is less than that reported in a previous study and close to percentage reported in study by Lam et al., (39%) [17] .
The incidence of adenocarcinoma in our study (29.5%) is higher than that reported in other studies 11.3%, 18.5% and 19.7% by Radzikowska et al. [11] , Shetty et al. [15] and Rawat et al. [12] , respectively.
There was a shift in the incidence of squamous cell carcinoma and adenocarcinoma, up to the late 1980s, squamous cell carcinoma was the most common subtype, which was then surpassed by adenocarcinoma. In recent years adenocarcinoma is the most common histologic subtype of lung cancer in most countries, accounting for almost half of all lung cancers [18] .
The shift in the incidence of squamous cell carcinoma and adenocarcinoma may be associated with the switch from non-filtered to filtered cigarettes, the depth of inhalation had been altered [19] .
In particular, smoke from unfiltered strong cigarettes may be shallowly inhaled, resulting in chemical carcinogen deposition centrally in the bronchial area and giving rise to squamous cell carcinomas. Smoke from filtered milder cigarettes may be more deeply inhaled, resulting in carcinogen deposition more peripherally and giving rise to adenocarcinomas. Reducing the nicotine content may also promote deeper inhalation as smokers attempt to compensate [20] . The changes in cigarette composition reduced the yield of carcinogenic polycyclic aromatic hydrocarbons (PAHs), inducers of squamous cell carcinomas, while increasing the yields of carcinogenic tobacco-specific N-nitrosamines (TSNAs), inducers of adenocarcinomas [21] .
Other possible explanations that the increasing use of mucin stains and immunocytochemical staining for antibodies to CEA has contributed to enhanced recognition of adenocarcinomas [15] .
These factors have contributed to the emerging predominance of adenocarcinoma in the lung cancer rates. Fig. 9 shows that adenocarcinoma was the predominant type (54.2%) in females followed by small cell carcinoma (16.7%) and squamous cell carcinoma (13.9%). In males the predominant type was squamous cell carcinoma (42.5%) followed by adenocarcinoma (14.5%).
The criteria of inoperability in our cases included: X-ray finding of chest wall invasion, finding of bilateral hilar or mediastinal enlargement suggestive of lymph node involvement, pleural effusion, mediastinal invasion and signs of vital structures involvement, presence of extrathoracic metastasis, bronchoscopic finding as vocal cord paralysis and tracheal or carinal involvement and the presence of supraclavicular lymph nodes metastasis.
The high percentage of inoperable cases in our study may be attributed to that some of the cases were misdiagnosed as tuberculosis and treated by anti-tuberculous treatment at other centers and after long time, the patients were referred to our chest department, thereby causing a delay in diagnosis, the smokers often explain any cough they experience as smoker's cough and this wrong belief may mask presence of tumor for a long time before diagnosis and thus delay diagnosis until the disease is at a more advanced. Lack of diagnostic facilities at peripheral health centers could be another cause for delay in diagnosis of bronchogenic carcinoma.
Conclusion
We can conclude from the study:
1. In this work, the highest incidence of bronchogenic carcinoma was in the sixth and seventh decades of life. The incidence declined before the age of 40 years and after the age of 70 years. 2. Smoking still remains the major risk factor in the pathogenesis of bronchogenic carcinoma. 3. On histological examination, squamous cell carcinoma was relatively more frequent than any other tumor type followed by adenocarcinoma and then by small cell carcinoma. 4. In all cell types of bronchogenic carcinoma, the mass lesion was the major radiological finding and the majority of cases were diagnosed by fibro-optic bronchoscopy.
